It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Alteration of the size and stiffness of the nucleus triggered by environmental cues are thought to be important for eukaryotic cell fate and function. However, it remains unclear how context-dependent nuclear remodeling occurs and reprograms gene expression. Here we identify the nuclear envelope proteins SUN1/2 as mechano-regulators of the nucleus during M1 polarization of the macrophage. Specifically, we show that LPS treatment decreases the protein levels of SUN1/2 in a CK2-βTrCP-dependent manner to shrink and soften the nucleus, therefore altering the chromatin accessibility for M1-associated gene expression. Notably, the transmembrane helix of SUN1/2 is solely required and sufficient for the nuclear mechano-remodeling. Consistently, SUN1/2 depletion in macrophages facilitates their phagocytosis, tissue infiltration, and proinflammatory cytokine production, thereby boosting the antitumor immunity in mice. Thus, our study demonstrates that, in response to inflammatory cues, SUN1/2 proteins act as mechano-regulators to remodel the nucleus and chromatin for M1 polarization of the macrophage.
Stiffness and size of the nucleus may affect the function of specific cell types. Here the authors show that LPS treatment of macrophages affects the nucleus stiffness and size involving nuclear envelope proteins SUN1/2, chromatin accessibility and M1 associated gene expression.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Fudan University, State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443)
2 University of Chinese Academy of Sciences, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China (GRID:grid.410726.6) (ISNI:0000 0004 1797 8419); Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
3 Fudan University Shanghai Medical College, Department of General Surgery, Hua’shan Hospital, Shanghai, China (GRID:grid.11841.3d) (ISNI:0000 0004 0619 8943)
4 Chinese Academy of Sciences, Shanghai Advanced Research Institute, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309)
5 Tongji University School of Medicine, Department of Stomatology, Department of Medical Ultrasound, Shanghai Tenth People’s Hospital, Department of Biochemistry and Molecular Biology, Shanghai, China (GRID:grid.24516.34) (ISNI:0000000123704535)
6 Fudan University, Department of Materials Science and State Key Laboratory of Molecular Engineering of Polymers, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443)
7 Tongji University School of Medicine, Department of General Surgery, Yangpu Hospital, Shanghai, China (GRID:grid.24516.34) (ISNI:0000000123704535)
8 Chinese Academy of Sciences, Shanghai Advanced Research Institute, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309); Binzhou Medical University, College of Pharmacy, Yantai, China (GRID:grid.440653.0) (ISNI:0000 0000 9588 091X)
9 Fudan University, State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); Tongji University School of Medicine, Department of Stomatology, Department of Medical Ultrasound, Shanghai Tenth People’s Hospital, Department of Biochemistry and Molecular Biology, Shanghai, China (GRID:grid.24516.34) (ISNI:0000000123704535); Nanjing Medical University, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984)